Antimicrobial and cancer cell growth inhibitory activities of 3β- acetoxy-17β-(L-prolyl)amino-5α-androstane in vitro

International Journal of Antimicrobial Agents

Volumn 15, Issue 4, 2000, Pages 299-304

  Pettit, Robin K ^a   Cage, Gary D ^b   Pettit, George R ^a   Liebman, Jessica A ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b Bur Stt Lab Serv Arizona D   (United States)

Author keywords

Antibacterial susceptibility; Steroidal amide

Indexed keywords

3BETA ACETOXY 17BETA (L PROLYL)AMINO 5ALPHA ANDROSTANE; ANDROSTANE DERIVATIVE; METICILLIN; PENICILLIN G; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MUTATION; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CORYNEBACTERIUM; DRUG SAFETY; DRUG STRUCTURE; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; LISTERIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NOCARDIA; NONHUMAN; PH; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANDROSTANES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; PROLINE; TUMOR CELLS, CULTURED;

EID: 0033853913     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00156-4     Document Type: Article

References (8)

1. Amyes S.G.B., Gemmell C.G. Antibiotic resistance. J. Med. Microbiol. 46:1997;436-470.
2. Pfaller MA, Jones RN, Doern GV, Kugler K, and the Sentry Participants Group. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998;42:1762-1770.
3. Pettit G.R., Smith R.L., Klinger H. Synthesis of 3β-Acetoxy-17β-(L-arginyl-L-arginyl-L-prolyl)amino-5α- androstane. J. Med. Chem. 10:1967;145-148.
4. Monks A., Scudiero D., Skehan P., Shoemaker R. et al. Feasability of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83:1991;757-766.
5. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard M2-A6. Wayne, PA: NCCLS, 1997.
6. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved standard M7-A4. Wayne, PA: NCCLS, 1997.
7. Bycroft BW, editor. Dictionary of Antibiotics and Related Substances. New York: Chapman and Hall, 1988.
8. Koll B.S., Brown A.E. The changing epidemiology of infections at cancer hospitals. Clin. Infect. Dis. 17(Suppl. 2):1993;S322-S328.